Literature DB >> 9562099

Orbital tumor in acute myeloid leukemia associated with karyotype 46,XX,t(8;21)(q22;q22): a case report.

M Tanigawa1, Y Tsuda, T Amemiya, K Yamada, M Nakayama, Y Tsuji.   

Abstract

Orbital tumor formation in acute myeloid leukemia (AML) is rare as an initial symptom. Furthermore, orbital granulocytic sarcoma (myeloid sarcoma) in pediatric patients is uncommon. We describe a 5-year-old Japanese girl with a left orbital mass as an initial symptom of AML, the mass revealed by computed tomography. Peripheral blood and bone marrow pictures and a chromosomal analysis disclosing 46,XX,t(8;21)(q22;q22) showed AML (M2 according to the French-American-British classification). She was treated with antileukemic chemotherapy systemically. Three weeks after the initiation of chemotherapy, the orbital tumor regressed markedly. AML as an initial symptom of the orbital mass should be fully considered in a differential diagnosis, even in the absence of typical leukemic symptoms, and chromosomal analysis and immunophenotypical analysis may explain the pathogenesis of the extramedullary leukemic tumor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9562099     DOI: 10.1159/000027279

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  3 in total

1.  Orbital granulocytic sarcoma in acute myelogenous leukemia.

Authors:  B N Lakhkar; S Banavali; P Philip
Journal:  Indian J Pediatr       Date:  2000-03       Impact factor: 1.967

2.  Bilateral orbital myeloid sarcoma as initial manifestation of acute myeloid leukemia.

Authors:  Kamel Hmidi; Sonia Zaouali; Riadh Messaoud; Bahri Mahjoub; Wafa Ammari; Leila Bacha; Adnene Laatiri; Salah Jenzeri; Moncef Khairallah
Journal:  Int Ophthalmol       Date:  2007-05-24       Impact factor: 2.029

3.  Granulocytic Sarcoma of Parotid Gland in a 4-Year-Old Child with Subleukemic AML: A Diagnostic Challenge!

Authors:  Yashwant Ingale; Tushar Patil; Priyanka Chaudhari; Samapika Routray; Manoj Agrawal
Journal:  Case Rep Otolaryngol       Date:  2013-09-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.